Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
Onderzoeksoutput
- 7 resultaten
Zoekresultaten
-
2024
Interleukin-18 Inhibition in Inflammatory Bowel Disease: A Delicate Balance
Geertsema, S., Fagundes, R. R., Otten, A. T., Dijkstra, G., Faber, K. N. & Bourgonje, A. R., apr.-2024, In: Inflammatory Bowel Diseases. 30, 4, blz. 693–694 2 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand2 Citaten (Scopus)18 Downloads (Pure) -
Letter: Diet-microbiome interactions in inflammatory bowel disease—Navigating towards individualised dietary strategies
Barth, I., Stevens, C. L., Strokap, C. J., Campmans-Kuijpers, M. J. E., Bourgonje, A. R. & Dijkstra, G., mei-2024, In: Alimentary Pharmacology & Therapeutics. 59, 9, blz. 1154-1155 2 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand14 Downloads (Pure) -
The Future of Therapeutic Drug Monitoring in Inflammatory Bowel Disease: An Emphasis on the Essential Ingredients
Otten, A. T., Dijkstra, G., Visschedijk, M. C. & Bourgonje, A. R., feb.-2024, In: Inflammatory Bowel Diseases. 30, 2, blz. 318-319 2 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand49 Downloads (Pure) -
2023
Assessment of Fecal Glycosylated Mucins as Novel Biomarkers in Inflammatory Bowel Diseases
Geertsema, S., Otten, A. T., Bouwknegt, D. G., Visschedijk, M. C. & Bourgonje, A. R., mrt.-2023, In: Inflammatory Bowel Diseases. 29, 3, 2 blz., izac265.Onderzoeksoutput › Academic › peer review
Open AccessBestand63 Downloads (Pure) -
Identifying Phenotypic Determinants of Infliximab Target Concentrations in Inflammatory Bowel Disease: Toward Personalized Evidence-Based Dosing Regimens
Bourgonje, A. R. & Mian, P., dec.-2023, In: The American Journal of Gastroenterology. 118, 12, blz. 2308-2309 2 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand2 Citaten (Scopus)24 Downloads (Pure) -
Letter: disentangling the role of redox-active compounds in the development of inflammatory bowel diseases – moving towards causal associations
Geertsema, S., van Goor, H., Dijkstra, G., Faber, K. N. & Bourgonje, A. R., mei-2023, In: Alimentary Pharmacology & Therapeutics. 57, 9, blz. 1046-1047 2 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand1 Citaat (Scopus)41 Downloads (Pure) -
The Risk of Developing Long COVID in Patients with Inflammatory Bowel Diseases: Do Immunosuppressive Drugs Matter?
Bourgonje, A. R. & Otten, A. T., jul.-2023, In: Clinical Gastroenterology and Hepatology. 21, 7, blz. 1971-1972 4 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand1 Citaat (Scopus)80 Downloads (Pure)